Achmea Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-97,921
Closed -$9.72M 563
2019
Q3
$9.72M Buy
97,921
+7,506
+8% +$713K 0.38% 54
2019
Q2
$8.36M Buy
90,415
+15,908
+21% +$1.51M 0.32% 72
2019
Q1
$7.03M Buy
74,507
+19,118
+35% +$1.67M 0.29% 82
2018
Q4
$3.55M Buy
55,389
+32,239
+139% +$2.38M 0.16% 140
2018
Q3
$2.07M Buy
23,150
+8,280
+56% +$732K 0.08% 274
2018
Q2
$1.18M Sell
14,870
-16,894
-53% -$1.4M 0.04% 345
2018
Q1
$2.83M Hold
31,764
0.1% 244
2017
Q4
$3.31M Buy
31,764
+10,759
+51% +$1.21M 0.11% 225
2017
Q3
$3.06M Sell
21,005
-2,961
-12% -$403K 0.17% 145
2017
Q2
$3.11M Sell
23,966
-30,316
-56% -$3.71M 0.19% 143
2017
Q1
$6.75M Buy
+54,282
New +$6.5M 0.32% 75

Other funds holding CELG

Achmea Investment Management's CELG Position: Q4 2019 in Review

Achmea Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 97,921 shares — an estimated $9.72M sold.

Achmea Investment Management first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $9.72M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Achmea Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Achmea Investment Management sold 97,921 Celgene Corp shares in Q4 2019, an estimated $9.72M.
  • Achmea Investment Management first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Achmea Investment Management's Celgene Corp position peaked at $9.72M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Achmea Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.